Small Cause, Great Impact: Modification of the Guanidine Group in the RGD Motif Controls Integrin Subtype Selectivity
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Small Cause, Great Impact: Modification of the Guanidine Group in the RGD Motif Controls Integrin Subtype Selectivity
Authors
Keywords
-
Journal
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
Volume 55, Issue 4, Pages 1540-1543
Publisher
Wiley
Online
2015-12-10
DOI
10.1002/anie.201508713
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synthesis of linear and cyclic guazatine derivatives endowed with antibacterial activity
- (2014) Giorgio Maccari et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Pharmacophoric Modifications Lead to Superpotent αvβ3 Integrin Ligands with Suppressed α5β1 Activity
- (2014) Stefanie Neubauer et al. JOURNAL OF MEDICINAL CHEMISTRY
- Selective Imaging of the Angiogenic Relevant Integrins α5β1 and αvβ3
- (2013) Stefanie Neubauer et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Integrin modulators: a patent review
- (2013) Tobias G Kapp et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Biselectivity of isoDGR Peptides for Fibronectin Binding Integrin Subtypes α5β1 and αvβ6: Conformational Control through Flanking Amino Acids
- (2013) Alexander Bochen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Tumor Targeting via Integrin Ligands
- (2013) Udaya Kiran Marelli et al. Frontiers in Oncology
- Functionalizing αvβ3- or α5β1-Selective Integrin Antagonists for Surface Coating: A Method To Discriminate Integrin Subtypes In Vitro
- (2012) Florian Rechenmacher et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Crystal structure of α5β1 integrin ectodomain: Atomic details of the fibronectin receptor
- (2012) Masamichi Nagae et al. JOURNAL OF CELL BIOLOGY
- Integrins as therapeutic targets
- (2012) Simon L. Goodman et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Cilengitide: The First Anti-Angiogenic Small Molecule Drug Candidate. Design, Synthesis and Clinical Evaluation
- (2011) Carlos Mas-Moruno et al. Anti-Cancer Agents in Medicinal Chemistry
- Conformational Control of Integrin-Subtype Selectivity in isoDGR Peptide Motifs: A Biological Switch
- (2010) Andreas O. Frank et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- NG-Acyl-argininamides as NPY Y1 receptor antagonists: Influence of structurally diverse acyl substituents on stability and affinity
- (2010) Stefan Weiss et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Conformations, Conformational Preferences, and Conformational Exchange of N′-SubstitutedN-Acylguanidines: Intermolecular Interactions Hold the Key
- (2010) Roland Kleinmaier et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- The final steps of integrin activation: the end game
- (2010) Sanford J. Shattil et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Antiangiogenic Effect of Dual/Selective α5β1/αvβ3Integrin Antagonists Designed on Partially Modified Retro-Inverso Cyclotetrapeptide Mimetics
- (2009) Luca Gentilucci et al. JOURNAL OF MEDICINAL CHEMISTRY
- Rational Design of Highly Active and Selective Ligands for the α5β1 Integrin Receptor
- (2008) Dominik Heckmann et al. CHEMBIOCHEM
- Discovery of Subnanomolar Arginine-Glycine-Aspartate-Based αVβ3/αVβ5Integrin Binders Embedding 4-Aminoproline Residues
- (2008) Franca Zanardi et al. JOURNAL OF MEDICINAL CHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started